Dr Vera Casslén has long experience as biomedical scientist. All her work has confined to translational research in preclinical stage with biomarker discovery, drug discovery, or early drug development. In 2002, Dr Casslén finished her PhD thesis with the title “Molecular and cellular mechanisms of tumor cell resistance to cytotoxic drugs”. After gaining international experience and scientific training in USA, Switzerland and the UK, Dr Casslén joined the Medical faculty at Lund University. In 2011 she left academia for work with start-up and small biotech companies. Joining Aptahem in 2019 as Senior Scientist, Dr Casslén supports the CSO with strategic and operative scientific work.
Theresa Comiskey Olsen